|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jan 03, 2018||referred to insurance|
senate Bill S7141
Archive: Last Bill Status - In Senate Committee Insurance Committee
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S7141 (ACTIVE) - Details
S7141 (ACTIVE) - Sponsor Memo
BILL NUMBER: S7141 SPONSOR: BROOKS TITLE OF BILL: An act to amend the insurance law, in relation to mandating insurance coverage for medical devices to treat withdrawal symptoms PURPOSE OR GENERAL IDEA OF BILL: Requires insurance companies to cover medications, medical devices or products approved by the Food and Drug Administration to treat with- drawal symptoms. SUMMARY OF SPECIFIC PROVISIONS: Sections 1 through 4 of the bill requires every policy that provides hospital, major medical or similar comprehensive coverage must also provide coverage for medical devices or products that treat withdrawal symptoms.
S7141 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 7141 I N S E N A T E (PREFILED) January 3, 2018 ___________ Introduced by Sen. BROOKS -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance AN ACT to amend the insurance law, in relation to mandating insurance coverage for medical devices to treat withdrawal symptoms THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subparagraph (A) of paragraph 30 of subsection (i) of section 3216 of the insurance law, as amended by section 1 of part B of chapter 71 of the laws of 2016, is amended to read as follows: (A) Every policy that provides hospital, major medical or similar comprehensive coverage must provide inpatient coverage for the diagnosis and treatment of substance use disorder, including detoxification and rehabilitation services, INCLUDING THE USE OF MEDICATIONS, MEDICAL DEVICES AND PRODUCTS APPROVED BY THE FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF WITHDRAWAL SYMPTOMS. Such inpatient coverage shall include unlimited medically necessary treatment for substance use disor- der treatment services provided in residential settings as required by the Mental Health Parity and Addiction Equity Act of 2008 (29 U.S.C. § 1185a). Further, such inpatient coverage shall not apply financial requirements or treatment limitations, including utilization review requirements, to inpatient substance use disorder benefits that are more restrictive than the predominant financial requirements and treatment limitations applied to substantially all medical and surgical benefits covered by the policy. Further, such coverage shall be provided consist- ent with the federal Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (29 U.S.C. § 1185a). § 2. Subparagraph (A) of paragraph 31 of subsection (i) of section 3216 of the insurance law, as added by chapter 41 of the laws of 2014, is amended to read as follows: (A) Every policy that provides medical, major medical or similar comprehensive-type coverage must provide outpatient coverage for the diagnosis and treatment of substance use disorder, including detoxifica- tion and rehabilitation services, INCLUDING THE USE OF MEDICATIONS,
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.